Financial Analysis

Note 9 Commitments and Contingencies Employment Agreements The Company has employment agreements in place for certain members of management. These employment agreements are for periods ranging from one to two years and contain certain provisions for severance payments in the event of certain events, including termination or change of control. Legal Proceedings On October 4, 2024, the Company filed a demand for arbitration (the Arbitration Demand) against Duke University with the American Arbitration Association alleging that Duke fraudulently induced the Company to enter its Patent and Technology License Agreement with Duke and that Duke breached the agreement on various occasions. The Arbitration Demand includes five counts against Duke, as follows: Count I Breach of the Duke License Agreement; Count II Breach of the Implied Contractual Covenant of Good Faith and Fair Dealing; Count III Fraudulent Inducement to Enter the Duke License Agreement; Count IV Violation of North Carolinas Unfair Trade Practices Act; and Count V Unjust Enrichment. In connection therewith, the Company has requested an award in the Companys favor and against Duke for damages in an amount to be proved at a final hearing, interest, attorneys fees, and arbitration fees and costs, along with all other relief to which the Company is entitled at law or in equity. On November 18, 2024, Duke responded to the Arbitration Demand and asserted counterclaims against the Company which Duke amended on March 24, 2025 …

CommitmentsAndContingenciesDisclosureTextBlock · excerpt; the full note is in the filing

Note 5 Notes Payable On July 18, 2022, Cryo-Cell International, Inc. (the Company) entered into a Credit Agreement (the Credit Agreement) with Susser Bank, a Texas state bank (Susser), as administrative agent on behalf of itself and the other lenders (collectively, the Lenders). The Credit Agreement provides for (i) an unsecured revolving line of credit with an aggregate commitment of up to $ 10,000,000 (the RCF) and (ii) a term loan facility in an original principal amount of $ 8,960,000 (the Term Loan, and together with the RCF, the Loans). In connection with the Credit Agreement, the Company executed a Revolving Credit Note in favor of Susser in the principal amount of $ 10,000,000 (the RCF Note) and a Term Note in favor of Susser in the principal amount of $ 8,960,000 (the Term Note, and together with the RCF Note, the Notes). The Loans bear interest, at the Companys option, at either (a) a base rate equal to the highest of (i) the U.S. Prime Rate as published by The Wall Street Journal , (ii) the federal funds rate plus 0.50 %, or (iii) the Monthly SOFR rate plus 1.00 %, subject in each case to a floor of 5.50 %, plus an applicable margin, or (b) the Monthly SOFR rate plus an applicable margin, subject to a floor of 4.50 %. Prior to the Fifth Amendment (defined below), the applicable margins were 4.25 % for Base Rate loans and 3.25 % for Monthly SOFR loans. The Company is also required to pay a commitment fee on the unused portion of the RCF. The RCF originally matured o …

DebtDisclosureTextBlock · excerpt; the full note is in the filing

Note 11 Leases The following table presents the right-of-use asset and short-term and long-term lease liabilities amounts recorded on the consolidated balance sheets as of May 31, 2026 and November 30, 2025: May 31, 2026 November 30, 2025 Assets Operating lease right-of-use asset $ 621,943 $ 819,626 Liabilities Current portion of operating lease liabilities $ 421,888 $ 430,221 Operating lease long-term liabilities 260,664 474,628 Total lease liability $ 682,552 $ 904,849 The maturity of the Companys lease liabilities at May 31, 2026 were as follows: Future Operating Fiscal Year Ending May 31, Lease Payments 2027 458,701 2028 267,225 Less: Imputed interest ( 43,374 ) Present value of lease liabilities $ 682,552 The remaining lease term and discount rates are as follows: May 31, 2026 November 30, 2025 Lease Term and Discount Rate Remaining lease term (years) Operating lease 1.57 2.03 Discount rate (percentage) Operating lease 7.5 % 7.5 % Supplemental cash flow information related to leases is as follows: Three months ended May 31, 2026 May 31, 2025 Operating cash outflows from operating leases $ 133,614 $ 126,629 Six months ended May 31, 2026 May 31, 2025 Operating cash outflows from operating leases $ 264,515 $ 253,257 …

LesseeOperatingLeasesTextBlock · excerpt; the full note is in the filing

"Recently Issued Accounting Pronouncements In September 2023, FASB issued ASU 2023-09, Improvements to Income Tax Disclosures. This ASU enhances and improves the income tax disclosure requirements under Topic 740, ""Income Taxes."" The key provisions of this update include additional disclosures related to income tax expense, unrecognized tax benefits, and the impact of tax rate changes on the financial statements. The Company is currently assessing the impact of ASU 2023-09 on its financial statement disclosures. The guidance is effective for fiscal years beginning after December 15, 2024. While the Company has not yet determined the full effect on its financial reporting, it is in the process of evaluating how to implement the required enhanced disclosures. This includes more detailed information on tax rate reconciliation, tax liabilities, and changes in unrecognized tax benefits. In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, Income StatementReporting Comprehensive Income (Subtopic 220-40): Disaggregation of Income Statement Expenses , which enhances the disclosure requirements for income statement expenses by requiring additional disaggregation of certain expense categories in the notes to the financial statements. In January 2025, the FASB issued ASU No. 2025-01, which clarified the effective dates related to this guidance. The amendments in this ASU are effective for annual reporting periods begin …

NewAccountingPronouncementsPolicyPolicyTextBlock · excerpt; the full note is in the filing

Note 2 Segment Reporting The Company is organized in three reportable segments: 1. The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use. Revenue is generated from the initial processing and testing fees and the annual storage fees charged each year for storage (the Umbilical cord blood and cord tissue stem cell service). 2. The manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells. Revenue is generated from the sales of the PrepaCyte CB units (the PrepaCyte-CB). 3. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. Revenue is generated from the sale of the cord blood units to the National Marrow Donor Program (NMDP), which distributes the cord blood units to transplant centers located in the United States, and around the world. The Companys chief operating decision makers (CODM) are its co-CEO s, who review financial information for the purposes of making operating decisions, assessing financial performance and allocating resources. The CODM uses net income as reported on the consolidated statements of operations to assess segment performance and determine how to allocate resources. Total assets as presented on the consolidated balance sheets are used to measure segment assets. The CODM reviews significant expense categories that materially align with those presented in the consolidated statements of operations. The fo …

SegmentReportingDisclosureTextBlock · excerpt; the full note is in the filing